Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023

Objective: This study investigates the utilisation of modern glucocorticoid medications (Acecort®, Alkindi®, Efmody®, and Plenadren®) for congenital adrenal hyperplasia due to 21-hydroxylase deficiency, examining prescribing patterns, barriers to adoption, and geographical and temporal trends. Metho...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	A Roxas, A Gihawi, M Makarchuk, J Bryce, M Chen, S F Ahmed, S R Ali, A Drake, M Casipe, L Groves, J Idkowiak, R Krone, C Flueck, A Nordenström, N Reisch, H L Claahsen – van der Grinten, B P H Adriaansen, N H Birkebaek, S Hannema, M W O Reilly, L Cussen, S P Zaric, U Neumann, F Baronio, A Vieites, G F Alonso, H Elsedfy, I Mazen, A Thankamony, J Witczak, D A Rees, N Atapattu, S N Seneviratne, M Cools, Hayat El Kaddouri, Alegria Ferri Perez, A Guven, S Poyrazoglu, A Fu, D Janus, E Globa, S Shenoy, C de Bruin, M Korbonits, S Adam, M Wasniewska, G Russo, F Phan-Hug, W Bonfig, M Salerno, J W Tomlinson, S Leka-Emiri, L de Vries, I Yarhere, G Guaranga-Filho, J van Eck, T A S S Bachega, N Krone, M De Bono, J H Davies, A Segev-Becker, V Iotova, N Lenherr-Taube, A German, R Giordano, L De Sanctis, U Probst, R Markosyan, D S Brewer, E C Costa, E A Webb
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Bioscientifica 2026-03-01
סדרה:	Endocrine Connections
נושאים:	congenital adrenal hyperplasia glucocorticoid prescribing hydrocortisone
גישה מקוונת:	https://ec.bioscientifica.com/view/journals/ec/15/3/EC-25-0565.xml
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!